![衛福部核可之細胞治療執行單位 [持續更新]](http://biomaptw.com/media/k2/items/cache/753a82091bdf93df272697e1f26229c2_XL.jpg)
Past events
新藥研發新走向，11/30 轉譯醫學與新藥開發策略分享交流會，名額有限！過去製藥產業總是投入大量時間與成本，成效卻無法顯現？！該如何降低製藥投入風險，提高藥品研發成本效益？11/30經濟部中小企業處辦理「轉譯醫學與新藥開發策略分享交流會」邀請產業專家共同分享交流。全福科技，具備國內轉譯科學領域之經驗與競爭力，整合虛擬團隊，致力於創新藥品的開發；台康生技，從事蛋白藥的生技藥品委託開發代工製造服務，與CMO共創雙贏合作策略。藉由新藥開發過程之經驗分享，期能協助企業主進行臨床應用與基礎醫學的整合，解決藥品開發之臨床需求與產業供應端等問題。加速臨床與基礎雙向驗證，有效應用並轉化為新的診斷與治療方法。想知道更多，立馬來報名！註：本次交流會為封閉式活動，與會者需憑報到通知單入場。
| Time | Topic and Speaker | |
|---|---|---|
| Time | Topic and Speaker | |
| 08:30 - 09:00 | Registration | |
| 09:00 - 09:05 | Opening Remarks Lawrence Gan, Ph.D Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals | |
| 09:05 - 09:10 | Herbert Wu, Ph.D. President, Development Center for Biotechnology | |
| Opening Keynote | ||
| Moderator 09:10 - 09:15 | Yun Yen, M.D., Ph.D. President Emeritus of Taipei Medical University, Chair Professor of the Ph.D. Program for Cancer Biology and Drug Discovery | |
| 09:15 - 10:00 | Cancer Cell Cast a Sweet Spell on Tumor Microenvironment: Opportunities and Challenges Alice Yu, M.D., Ph.D. Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital | |
| 10:00 - 10:30 | Break | |
| Moderator 10:30 - 10:35 | Shie-Liang Edmond Hsieh, M.D., D.Phil. Distinguished Research Fellow, Genomics Research Center, Academia Sinica | |
| 10:35 - 11:05 | Defining the Difference: Developing Translational Screening Models to Mimic Tumor Microenvironment Litao Zhang, Ph.D. VP, Leads Discovery & Optimization R&D, Bristol-Myers Squibb | |
| 11:05 - 11:35 | What You Eat Makes You Strong but Vulnerable : Metabolic Targeting of Intramural Tregs in Cancer Immunotherapy Ping-Chih Ho, Ph.D. Assistant Professor/Ludwig adjunct scientist Department of oncology UNIL CHUV/Ludwig Institute for Cancer Research Lausanne | |
| 11:35 - 12:05 | Finding Better Combinations of Immunotherapy Keng-Li Lan, M.D., Ph.D. Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University;Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital | |
| 12:05 - 13:40 | Lunch (Taiwan Antibody Association Members Meeting and Poster Viewing) | |
| 12:15 - 12:45 | Lunch Panel / Industry satellite symposium | |
| Moderator 13:40 - 13:45 | Ping-Ning Hsu, M.D., Ph.D. Professor, Graduate Institute of Immunology, College of Medicine, National Taiwan University | |
| 13:45 - 14:15 | Understanding Immune Checkpoint TIM-3 Biology and TIM-3 Antibody for Cancer Immunotherapy Xiaomo Jiang , Ph.D. Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research | |
| 14:15 - 14:45 | Clinical Experience and Safety Management of Immunotherapy John Wen-Cheng Chang, M.D. Chief, Division of Medical Oncology, Chang Gung Memorial Hospital; Director, Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital; Chairman, Taiwan Society for Immunotherapy of Cancer | |
| 14:45 - 15:15 | Current Progress of Immunotherapy for Non-small Cell Lung Cancer Chih-Hsin Yang, M.D., Ph.D. Professor & Director, Graduate Institute of Oncology, College of Medicine, National Taiwan University | |
| 15:15 - 15:45 | Break | |
| 15:45 - 16:00 | Poster Award | |
| Closing Keynote | ||
| Moderator 16:00 - 16:05 | Herbert Wu, Ph.D. President, Development Center for Biotechnology | |
| 16:05 - 16:50 | Engineering Adaptive Cell and Gene Therapies Timothy K. Lu, Ph.D. Associate Professor Synthetic Biology Group, Research Laboratory of Electronics, Electrical Engineering and Computer Science, Biological Engineering, Massachusetts Institute of Technology | |
| 16:50 - 17:00 | Closing Remarks Herbert Wu, Ph.D. President, Development Center for Biotechnology |
New Articles
Cell Therapy
